Receptores solubles de la interleucina 2 y del factor de necrosis tumoral en la cirrosis hepática de diversas etiologías. Relación con el pronóstico y la gravedad clínica
Soluble interleukin-2 and tumor necrosis factor receptor in liver cirrhosis. Relationship with clinical severity and prognosis
Leído
4480
Vecesse ha leído el artículo
208
Total PDF
4272
Total HTML
Información del artículo
ISSN: 00257753Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 44 | 0 | 44 |
| 2025 9 | 30 | 0 | 30 |
| 2025 8 | 21 | 0 | 21 |
| 2025 7 | 47 | 0 | 47 |
| 2025 6 | 50 | 0 | 50 |
| 2025 5 | 53 | 0 | 53 |
| 2025 4 | 67 | 0 | 67 |
| 2025 3 | 95 | 2 | 97 |
| 2025 2 | 67 | 0 | 67 |
| 2025 1 | 88 | 0 | 88 |
| 2024 12 | 63 | 0 | 63 |
| 2024 11 | 65 | 0 | 65 |
| 2024 10 | 92 | 0 | 92 |
| 2024 9 | 73 | 0 | 73 |
| 2024 8 | 52 | 0 | 52 |
| 2024 7 | 52 | 0 | 52 |
| 2024 6 | 38 | 0 | 38 |
| 2024 5 | 57 | 0 | 57 |
| 2024 4 | 58 | 0 | 58 |
| 2024 3 | 37 | 0 | 37 |
| 2024 2 | 41 | 0 | 41 |
| 2024 1 | 59 | 0 | 59 |
| 2023 12 | 33 | 0 | 33 |
| 2023 11 | 66 | 0 | 66 |
| 2023 10 | 57 | 0 | 57 |
| 2023 9 | 37 | 0 | 37 |
| 2023 8 | 41 | 0 | 41 |
| 2023 7 | 34 | 0 | 34 |
| 2023 6 | 28 | 0 | 28 |
| 2023 5 | 38 | 0 | 38 |
| 2023 4 | 16 | 1 | 17 |
| 2023 3 | 13 | 0 | 13 |
| 2023 2 | 10 | 0 | 10 |
| 2022 1 | 4 | 1 | 5 |
| 2022 12 | 8 | 0 | 8 |
| 2022 11 | 13 | 0 | 13 |
| 2022 10 | 1 | 0 | 1 |
| 2022 9 | 3 | 0 | 3 |
| 2022 8 | 6 | 0 | 6 |
| 2022 7 | 2 | 0 | 2 |
| 2022 6 | 4 | 0 | 4 |
| 2022 5 | 4 | 0 | 4 |
| 2022 4 | 2 | 0 | 2 |
| 2022 3 | 281 | 0 | 281 |
| 2021 1 | 1 | 0 | 1 |
| 2021 12 | 1 | 0 | 1 |
| 2021 9 | 1 | 0 | 1 |
| 2021 8 | 1 | 2 | 3 |
| 2021 7 | 2 | 0 | 2 |
| 2021 6 | 1 | 0 | 1 |
| 2021 4 | 4 | 0 | 4 |
| 2020 10 | 8 | 0 | 8 |
| 2020 9 | 1 | 0 | 1 |
| 2020 8 | 1 | 0 | 1 |
| 2020 6 | 6 | 0 | 6 |
| 2020 5 | 2 | 0 | 2 |
| 2020 3 | 1 | 0 | 1 |
| 2020 1 | 1 | 0 | 1 |
| 2019 12 | 1 | 0 | 1 |
| 2019 11 | 1 | 0 | 1 |
| 2019 10 | 2 | 0 | 2 |
| 2019 9 | 1 | 0 | 1 |
| 2019 8 | 1 | 0 | 1 |
| 2019 7 | 1 | 0 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2017 10 | 10 | 1 | 11 |
| 2017 9 | 17 | 0 | 17 |
| 2017 8 | 8 | 2 | 10 |
| 2017 7 | 14 | 2 | 16 |
| 2017 6 | 20 | 3 | 23 |
| 2017 5 | 29 | 1 | 30 |
| 2017 4 | 16 | 3 | 19 |
| 2017 3 | 28 | 35 | 63 |
| 2017 2 | 25 | 6 | 31 |
| 2016 1 | 16 | 1 | 17 |
| 2016 12 | 26 | 4 | 30 |
| 2016 11 | 44 | 2 | 46 |
| 2016 10 | 55 | 1 | 56 |
| 2016 9 | 35 | 7 | 42 |
| 2016 8 | 28 | 5 | 33 |
| 2016 7 | 23 | 1 | 24 |
| 2016 6 | 32 | 6 | 38 |
| 2016 5 | 37 | 6 | 43 |
| 2016 4 | 27 | 6 | 33 |
| 2016 3 | 16 | 3 | 19 |
| 2016 2 | 22 | 3 | 25 |
| 2015 1 | 31 | 5 | 36 |
| 2015 12 | 15 | 4 | 19 |
| 2015 11 | 27 | 3 | 30 |
| 2015 10 | 34 | 8 | 42 |
| 2015 9 | 36 | 6 | 42 |
| 2015 8 | 10 | 2 | 12 |
| 2015 7 | 14 | 8 | 22 |
| 2015 6 | 9 | 1 | 10 |
| 2015 5 | 14 | 2 | 16 |
| 2015 4 | 10 | 10 | 20 |
| 2015 3 | 10 | 4 | 14 |
| 2015 2 | 15 | 2 | 17 |
| 2015 1 | 31 | 4 | 35 |
| 2014 12 | 39 | 4 | 43 |
| 2014 11 | 31 | 1 | 32 |
| 2014 10 | 41 | 2 | 43 |
| 2014 9 | 34 | 2 | 36 |
| 2014 8 | 32 | 5 | 37 |
| 2014 7 | 49 | 2 | 51 |
| 2014 6 | 33 | 4 | 37 |
| 2014 5 | 27 | 2 | 29 |
| 2014 4 | 20 | 2 | 22 |
| 2014 3 | 27 | 4 | 31 |
| 2014 2 | 26 | 2 | 28 |
| 2014 1 | 23 | 2 | 25 |
| 2013 12 | 23 | 2 | 25 |
| 2013 11 | 32 | 4 | 36 |
| 2013 10 | 25 | 4 | 29 |
| 2013 9 | 15 | 1 | 16 |
| 2013 8 | 26 | 1 | 27 |
| 2013 7 | 20 | 1 | 21 |
| 2013 5 | 1 | 0 | 1 |
| 2004 4 | 975 | 0 | 975 |
Mostrar todo
